Int J Epidemiol Res. 2018;5(1): 30-33. doi: 10.15171/ijer.2018.07

Review Article

Multiple Sclerosis in Iran

Reza Sahebi 1, Masoud Amiri 2, Mohammad Saeid Jami 1

Cited by CrossRef: 5

1- Samangooei M, Farjam M, Niknam Z, Etemadifar M, Meshkibaf M, Noroozi S. Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing–remitting multiple sclerosis patients and their first-degree family. Metab Brain Dis. 2021;36(7):1929 [Crossref]
2- Saadat S, Kajbaf M, Kalantari M, Hosseininezhad M. The Multiple Sclerosis Self-Management Scale–Revised (MSSM-R). 2020;22(1):37 [Crossref]
3- Moosavi E, Rafiei A, Yazdani Y, Eslami M, Saeedi M. Association of serum levels and receptor genes BsmI, TaqI and FokI polymorphisms of vitamin D with the severity of multiple sclerosis. Journal of Clinical Neuroscience. 2021;84:75 [Crossref]
4- Safian A, Davodvand S, Masoudi R, Sedehi M, Tahmasebian S, Jivad N. The effect of mobile-based self-care program on balance of people with Multiple Sclerosis. IJRN. 2020;7(1):33 [Crossref]
5- Baghbanian S, Cheraghmakani H, HabibiSaravi R, Azar A, Ghasemihamedani F. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018. BMC Neurol. 2020;20(1) [Crossref]


Reza Imani   

Associate Professor of Infectious Diseases, Department of Infectious Diseases, Social Determinants of Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran. 

 Email: eimani@skums.ac.ir



Soleiman Kheiri  

Professor of Biostatistics, Department of Epidemiology and Biostatistics, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran. 

 Email: kheiri@skums.ac.ir

Indexing & Abstracting








Follower of



 Powered by